This suggests that EPHB6 does not have a blanket effect on TICs, but most likely promotes specific subsets of these cells, and agrees very well with TIC heterogeneity, which results from the evolution of TICs in developing tumours [52, 53]. The gene discussed is EPHB6; the disease is neoplasm.